Adiponectin has been recognized as a potent regulator of metabolism possessing anti-inflammatory and anti-atherogenic functions and inversely associated with increasing incidents of type 2 diabetes and obesity. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.